Trials / Withdrawn
WithdrawnNCT01978821
Stem Cell Therapy for Cerebral Palsy
Open Label Study of Autologous Bone Marrow Mononuclear Cells in Cerebral Palsy
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Neurogen Brain and Spine Institute · Academic / Other
- Sex
- All
- Age
- 17 Months – 22 Years
- Healthy volunteers
- Not accepted
Summary
the purpose of this study was to study the effect of stem cell therapy on common symptoms of cerebral palsy patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Autologous bone marrow mononuclear cell transplantation |
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2013-08-01
- Completion
- 2013-08-01
- First posted
- 2013-11-08
- Last updated
- 2018-10-25
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT01978821. Inclusion in this directory is not an endorsement.